This article defines and studies a stochastic process that combines two important stylized facts of financial data: reversion to the mean, and a flexible generalized stochastic volatility process: the 4/2 process. This work is motivated by the modeling of at least two financial asset classes: commodities and volatility indexes. We provide analytical expressions for the conditional characteristic functions and closed-form approximations to relevant cases, in particular a mean-reverting Heston stochastic volatility model. Our results describe feasible changes of measure with the final aim of pricing financial derivatives. The empirical analysis and the estimation methodology confirm the need of such a model in several examples from the targeted asset classes. Applications to option pricing corroborate the substantial impact on the implied volatility surfaces of the new parameters.
This paper proposes and investigates a multivariate 4/2 Factor Model. The name 4/2 comes from the superposition of a CIR term and a 3/2-model component. Our model goes multidimensional along the lines of a principal component and factor covariance decomposition. We find conditions for well-defined changes of measure and we also find two key characteristic functions in closed-form, which help with pricing and risk measure calculations. In a numerical example, we demonstrate the significant impact of the newly added 3/2 component (parameter b) and the common factor (a), both with respect to changes on the implied volatility surface (up to 100%) and on two risk measures: value at risk and expected shortfall where an increase of up to 29% was detected.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.